Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Development of FAK Inhibitors: A Five-Year Update
Andrea Spallarossa, Bruno Tasso, Eleonora Russo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6381-6381
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 19
Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy
Jiaqiang Xiong, Rourou Xiao, Jiahui Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders
Ming Yang, Hua Xiang, Guoshun Luo
Biochemical Pharmacology (2024) Vol. 224, pp. 116246-116246
Closed Access | Times Cited: 8
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Baoyuan Zhang, Ning Li, Jiaming Gao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Integrin and Its Associated Proteins as a Mediator for Mechano-Signal Transduction
Kazuo Katoh
Biomolecules (2025) Vol. 15, Iss. 2, pp. 166-166
Open Access
A bioactive polysaccharide derived from Rosa laevigata fruits: Structural properties, antitumor efficacy, and potential mechanisms
Xiaoyang Guo, Fan Nie, Haojing Jiang, et al.
International Journal of Biological Macromolecules (2025), pp. 140382-140382
Closed Access
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study
Jiaming Gao, Jingwen Cheng, Wanyu Xie, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 6, pp. 639-651
Closed Access | Times Cited: 4
Design, synthesis and biological evaluation of liposome entrapped iridium(III) complexes toward SGC-7901 cells
Yi-Chuan Chen, Yiying Gu, Huiyan Hu, et al.
Journal of Inorganic Biochemistry (2023) Vol. 241, pp. 112134-112134
Closed Access | Times Cited: 13
Design, synthesis and evaluation of nitric oxide releasing derivatives of 2,4-diaminopyrimidine as novel FAK inhibitors for intervention of metastatic triple-negative breast cancer
Jinlin Zhang, Kang Xu, Fei Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 250, pp. 115192-115192
Closed Access | Times Cited: 12
Survival mechanisms of circulating tumor cells and their implications for cancer treatment
Shuang Zhou, Huanji Xu, Yichun Duan, et al.
Cancer and Metastasis Reviews (2024)
Closed Access | Times Cited: 3
Live Cell Screening to Identify RNA-Binding Small Molecule Inhibitors of the pre-let-7-Lin28 RNA-Protein Interaction
Sydney L. Rosenblum, Dalia M. Soueid, George M. Giambaşu, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1539-1546
Open Access | Times Cited: 3
Advances in research on the relationship between thymoquinone and pancreatic cancer
Zhanxue Zhao, Linxun Liu, Shuai Li, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 9
PYK2, a hub of signaling networks in breast cancer progression
Hava Gil-Henn, Jean‐Antoine Girault, Sima Lev
Trends in Cell Biology (2023) Vol. 34, Iss. 4, pp. 312-326
Closed Access | Times Cited: 9
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 8
Focal adhesion kinase signaling – tumor vulnerabilities and clinical opportunities
David D. Schlaepfer, Marjaana Ojalill, Dwayne G. Stupack
Journal of Cell Science (2024) Vol. 137, Iss. 14
Open Access | Times Cited: 2
Discovery of novel pyrrolo [2,3-d] pyrimidine derivatives as potent FAK inhibitors based on cyclization strategy
Shenxin Zeng, Shuai Yuan, Yu Zhang, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106713-106713
Closed Access | Times Cited: 7
Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach
Vikas Kumar, Pooja Singh, Shraddha Parate, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 130, pp. 108789-108789
Closed Access | Times Cited: 1
Computational investigation of novel pyrimidine derivatives as potent FAK inhibitorsvia3D-QSAR, molecular docking, molecular dynamics simulation and retrosynthesis
Salma El Bahi, Meryem Boutalaka, Moulay Ahfid El Alaouy, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 27, pp. 12816-12829
Closed Access | Times Cited: 4
PLA2R1 Inhibits Differentiated Thyroid Cancer Proliferation and Migration via the FN1-Mediated ITGB1/FAK Axis
Hui Zheng, Meng-Yu Zhang, Dingwei Gao, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2720-2720
Open Access | Times Cited: 3
Three-Dimensional-QSAR and Relative Binding Affinity Estimation of Focal Adhesion Kinase Inhibitors
Suparna Ghosh, Seung Joo Cho
Molecules (2023) Vol. 28, Iss. 3, pp. 1464-1464
Open Access | Times Cited: 2
On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence
Thorsten Steinberg, Martin Philipp Dieterle, Imke Ramminger, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12677-12677
Open Access | Times Cited: 2
Design, Synthesis, Biological Evaluation and Molecular Docking of Novel F-18-Labeled Focal Adhesion Kinase Inhibitors as Potential Tumor Radiotracers
Hailong Yang, Ye Li, Huaju Liang, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1224-1224
Open Access
Identification of potential FAK inhibitors using mol2vec molecular descriptor-based QSAR, molecular docking, ADMET study, and molecular dynamics simulation
Nguyễn Thu Hằng, Than Thi Kieu My, Le Thi Van Anh, et al.
Molecular Diversity (2024) Vol. 28, Iss. 4, pp. 2163-2175
Closed Access
Medicinal attributes of thienopyrimidine scaffolds incorporating the aryl urea motif as potential anticancer candidates via VEGFR inhibition
Myrna A. Farag, Manal M. Kandeel, Asmaa E. Kassab, et al.
Archiv der Pharmazie (2024)
Closed Access
Page 1 - Next Page

Scroll to top